Glucose Variability With DPP-4 Inhibition

• Status: Unknown status
• Trial end date: 2013-10-01
• Target enrollment: 0
• Participant gender: All

Summary

Glucose Variability With DPP-4 Inhibition

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Research Clinical Centre of the Russian Railways, JSC
• Treatments: Metformin; Sitagliptin Phosphate

Criteria

Inclusion Criteria:

• Type 2 diabetes

• receiving a stable dose of metformin ≥ 1500 mg

• HbA1c 7,5% -10/0 %

Exclusion Criteria:

• Type 1 diabetes

• HbA1c < 7,5% and > 10,0%